Concepedia

David J. Graham

DJ

Statistics

Publications

83

Citations

7.5K

H-Index

38

Active since

1987

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Acumen (United States)

Centers for Medicare and Medicaid Services

Kaiser Permanente

David J. Graham is an author at United States Food and Drug Administration specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Publications per year

1987–2024

83

Publications

83

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

David J. Graham, David Campen, Rita L. Hui et al. · The Lancet · 2005 · 912 citations

, , +13

Incidence of Hospitalized Rhabdomyolysis in Patients Treated With Lipid-Lowering Drugs

David J. Graham · JAMA · 2004 · 881 citations

, , +7

Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation

David J. Graham, Marsha E. Reichman, Michael Wernecke et al. · Circulation · 2014 · 644 citations · Full text

, , +17

Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone

David J. Graham, Rita Ouellet‐Hellstrom, Thomas MaCurdy et al. · JAMA · 2010 · 511 citations

, , +16

Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation

David J. Graham, Marsha E. Reichman, Michael Wernecke et al. · JAMA Internal Medicine · 2016 · 322 citations

, , +17

1–5 of 83